Anthera Pharmaceuticals (ANTH) Completes 33 Million Share Offering; Exercise in Full of Over-Allotment Option
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) has completed the previously announced underwritten public offering of 33,000,000 shares of its common stock, offered at a price to the public of $1.00 per share. In addition, the Company has sold 4,950,000 shares of its common stock at a price to the public of $1.00 per share pursuant to the underwriters' option to purchase additional shares, resulting in a total public offering of 37,950,000 shares. The gross proceeds to the Company from the sale of shares in this offering, before deducting customary underwriting discounts and commissions, were $37,950,000. Anthera intends to use the net proceeds from this offering for general corporate purposes.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cellectar Biosciences (CLRB) Files 300k Common Stock Shelf for Selling Shareholders
- HealthEquity (HQY) Prices 2.5M Secondary Stock Offering for Proceeds of ~$89.6M
- New Mountain Finance (NMFC) Announces 5M Share Common Stock Offering